



























Submitted to the Graduate Faculty of the 
 
Graduate School of Public Health in partial fulfillment 
  
of the requirements for the degree of 
 














Committee Membership Page 
UNIVERSITY OF PITTSBURGH 
 


















It was defended on 
 
April 12, 2021 
 
and approved by 
 
Mackey Friedman, PhD, MPH, Assistant Professor, Department of Infectious Diseases and 
Microbiology, Graduate School of Public Health, University of Pittsburgh 
 
MarthaAnn Terry, PhD, Associate Professor and Director of the Master’s Program, Behavioral 
and Community Health Sciences, Graduate School of Public Health, University of Pittsburgh 
 
Teagen L. O’Malley, PhD, MPH, Postdoctoral Associate, Department of Infectious Diseases and 
Microbiology, Graduate School of Public Health, University of Pittsburgh 
 
Thesis Advisor: Sarah Krier, PhD, MPH, Assistant Professor, Department of Infectious Diseases 

































PrEP and Women: Increasing Uptake and Continued Use 
 
Gabrielle Kyle-Lion, MPH 
 





Human immunodeficiency virus (HIV) remains a significant public health issue globally. While 
HIV prevention efforts have largely focused on men who have sex with men, in recent years, 
women have taken on a large percentage of disease burden, especially Black women. HIV can be 
prevented through the use of pre-exposure prophylaxis (PrEP). However, research suggests that 
women are rarely ever prescribed PrEP and if they do take it, they eventually discontinue use. 
Understanding the reasons why women are not taking PrEP is paramount in fighting the HIV 
epidemic.  
This master’s thesis engages multiple methods to discuss the opportunity of PrEP as an HIV risk 
reduction strategy for women and to investigate the context of women’s PrEP decision-making 
and intervention opportunities to support women’s uptake and adherence to PrEP. An analysis of 
interviews conducted with women in Pittsburgh, PA through the STD-to-PrEP Demonstration 
project suggest that women face many barriers to use PrEP and that current approaches to PrEP 
care are insufficient in meeting the everyday needs of women. A rapid review of literature showed 
the lack of intervention strategies for women. The public health significance of this research is that 
it shows the need for robust and targeted women-centered PrEP interventions that address 
women’s concerns by providing effective solutions through individualized approaches.  
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1.0 Introduction 
Human Immunodeficiency Virus (HIV) remains a significant public health issue for women 
worldwide. Globally, there are approximately 38 million people living with HIV, with about 1.7 
million new diagnoses observed in 2019 [World Health Organization (WHO), 2020]; 48% of new 
diagnoses were among women [UNAIDS, 2020]. In the United States (US) there were 37,968 new 
HIV diagnoses in 2018 [Centers for Disease Control and Prevention, 2020], where close to a fifth 
(19%) were among women [Centers for Disease Control and Prevention, 2020]. Women of color 
are disproportionately affected by HIV in the US. Forty two percent of new HIV diagnoses in 2018 
were among Black or African American individuals [Centers for Disease Control and Prevention, 
2020]. Approved by the Food and Drug Administration (FDA) in 2012, PrEP is an established 
biobehavioral HIV prevention method, though remains significantly underused by women in the 
US [“PrEP for Women”, 2019]. Approximately 5% of US PrEP prescriptions filled in 2016 were 
among women [Huang et al., 2016].  This master’s thesis discusses the opportunity of pre-exposure 
prophylaxis (PrEP) as an HIV risk reduction strategy for women and investigates the context of 
women’s PrEP decision-making and intervention opportunities to support women’s uptake and 
adherence to PrEP. 
The research on which this thesis is based used multiple methods to understand the factors that 
influence women’s decision-making process in taking PrEP, as well as to understand what 
interventions currently exist to support women’s PrEP use. A content analysis of qualitative 
interview transcripts (n=10) collected by STD-to-PrEP Demonstration Project, a longitudinal 
study investigating barriers and facilitators across the PrEP care continuum, examined factors 
influencing the PrEP decision-making process. A rapid review of literature identified existing peer-
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reviewed literature of PrEP interventions for women. While this is a small and specific subset of 
women enrolled in a demonstration project in Pittsburgh, their input allows us to better understand 
barriers and facilitators to women’s PrEP use, and together with evidence from the literature 
review, determine public health implications and recommendations for supporting women and 
PrEP use.  
The specific aims of this thesis are to:  
1. Understand how women describe their PrEP decision-making process, including 
barriers and facilitators to use, among a sub-sample of women in Pittsburgh, 
Pennsylvania.  
2.  Identify and synthesize existing peer-reviewed published literature focused on 
interventions around women’s PrEP engagement.  
3.  Discuss implications on public health practice and intervention development for 
women and PrEP.  
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2.0 Background 
2.1 HIV Among Women in the United States 
HIV remains a significant public health issue for women worldwide. According to UNAIDS, of 
the 1.7 million new cases of HIV in 2019, women accounted for 48% of those cases [2020]. Of 
the nearly 38,000 new HIV diagnoses in the US, 16% were women [Centers for Disease Control 
and Prevention, 2020]. 64.5% of those diagnoses were among Black women [Centers for Disease 
Control and Prevention, 2020]. According to the Centers for Disease Control and Prevention 
(CDC), when looking at categories for most-affected populations, Black women who participate 
in heterosexual contact had more cases than Black men who have heterosexual contact, Hispanic 
women/Latinas who have heterosexual contact, and White women who have heterosexual contact 
[2020]. Further, the majority of these women are from southern states, which have the highest 
burden of HIV with a rate of 15.6 per 100,000 people for new HIV diagnoses [Centers for Disease 
Control and Prevention, 2020].  
2.2 HIV Risk Reduction/Prevention Strategies for Women 
Current HIV prevention strategies include PrEP, male and female condoms, abstinence, regular 
STI testing and treatment, using clean needles when injecting drugs, and syringe services programs 
[Centers for Disease Control and Prevention, 2020]. While these are all considered effective 
methods of prevention by the CDC, barriers to use among women remain. Condoms are effective 
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at preventing HIV and other STIs though many women reported in the literature cited that they did 
not want to use condoms [Carley et al., 2019]. For example, a study in Zimbabwe that examined 
levels of prevention coverage among female sex workers (FSW) found that almost half of the 
women who were adherent to condoms and/or PrEP needed additional strategies [Fearon et al., 
2019]. Gaps in condom use adherence were observed by source of condom [Fearon et al., 2019]. 
For example, women used condoms when they received the condoms from a peer educator but did 
not use them if they came from a client [Fearon et al., 2019].].  
STI testing is also an HIV risk reduction option. Health care settings such as Planned Parenthood 
and other similar clinics offer testing and treatment at little to no cost. However, STI and HIV-
related stigma remains, and women are often discouraged from testing [Balfe et al., 2010]. In a 
study that looked at chlamydia testing specifically, women “strongly associated chlamydia and 
chlamydia testing with stigma and felt that only irresponsible, promiscuous risk takers were at risk 
of contracting infection” [Balfe et al., 2010, pg. 131].  
Finally, clean needles and syringe service programs offer another HIV risk reduction strategy. 
In a study looking at barriers to syringe service programs, the most frequently reported barriers 
were “being unaware of the existence, never having a problem obtaining clean needles, and fear 
of being seen or disclosing drug use” [Lancaster et al., 2020, pg. 2268].  
2.3 PrEP Among Women 
Given the limitations of existing HIV prevention options, PrEP, a biobehavioral HIV risk 
reduction strategy, offers an opportunity to expand prevention strategies for women. Approved by 
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the FDA in 2012, PrEP, a daily oral emtricitabine-tenofovir (Truvada) medication with a fixed-
dose combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC), is a valued 
component of HIV prevention in the US. In 2014 CDC recommended PrEP as a biobehavioral 
prevention method to reduce HIV incidence among people who are uninfected but at high risk for 
HIV acquisition [“PrEP for Women”, 2019]. PrEP is 99% effective if taken as prescribed [“PrEP 
for Women”, 2019]. In the US, an estimated one million people are eligible to use PrEP [30]. 
Despite this, prescription numbers remain relatively low. In 2018, approximately 78,000 persons 
filled prescriptions for PrEP, the majority of which (68.7%) were white [Huang et al., 2016] and 
only 7% were women [AIDSVu, 2018]. This highlights the need for understanding the barriers 
and facilitators to PrEP uptake among women.  
Current CDC eligibility guidelines for PrEP may present challenges to women being prescribed 
PrEP. Existing literature suggests that these guidelines may be too restrictive when it comes to 
women, and health care providers may be missing opportunities to prescribe PrEP to women who 
would benefit from its use. One study at a Planned Parenthood in Connecticut found that of women 
who reported known HIV risk factors or motivation to take PrEP were not considered PrEP eligible 
by existing CDC guidelines [Calabrese et al, 2019]. The authors suggest that current eligibility 
guidelines are focused on past/current actions and not on future actions/intentions that may put 
women at risk resulting in many women not considered good PrEP candidates [Calabrese et al., 
2019]. Another article that reviewed charts from a sexual health clinic found that the majority of 
women taking PrEP are those in sero-discordant relationships and that high-risk women might be 
not being considered for PrEP use [Blackstock et al., 2017].  
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2.4 Barriers to Women’s Use of PrEP 
Because of the diversity in a broad population like women, a number of barriers have been 
reported to using PrEP. In a study that surveyed women in high HIV burden counties, they found 
the following barriers to be most commonly reported: poverty, incarceration, unemployment, 
distrust of providers and locations where HIV prevention services are offered, displeasures 
associated with safer sex practices, intimate partner violence (IPV), challenges related to gendered 
power, cultural issues, stigma associated with HIV and women’s sexual behavior, and a lack of 
intervention strategies that address risk across multiple levels [Abrams et al., 2020]. Another 
article among women attending an obstetrics and gynecology clinic found that potential PrEP 
barriers included the need to use a condom, cost, daily adherence, short-term side effects, long-
term risk of kidney disease and decreased bone density, necessity of seeing a health care provider 
four times per year and picking up medications monthly [Carley et al., 2019]. In general, the 
literature tended to divide women into five different groups: (1) people who inject drugs (PWID); 
(2) intimate partner violence (IPV); (3) Black women; (4) female sex workers (FSW); and (5) 
adolescent girls and young women (AGYW). 
In another study with PWID assessing barriers to PrEP use, they split barriers up into individual, 
interpersonal, clinical and structural levels [Biello et al., 2018]. At the individual level were low 
PrEP knowledge and limited HIV risk perception, concerns about side effects, and competing 
health priorities and needs due to drug use and dependence. At the interpersonal level they reported 
negative experiences with healthcare providers and HIV-related stigma within social networks. 
The clinical and structural level barriers included poor infrastructure for PrEP delivery and low 
provider capacity/willingness to prescribe PrEP to PWID, the process of obtaining PrEP, 
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homelessness, criminal justice system involvement, lack of money or identification to fill 
prescriptions, and transportation difficulties [Biello et al., 2018].  In a study that examined PrEP 
in PWID in Washington, DC, the authors found that barriers to PrEP use included provider 
education and willingness to prescribe PrEP [Kuo et al., 2016].  
Several studies examined barriers to PrEP for women who experience IPV. One study found 
barriers such as fear of side effects/negative health outcomes, low risk perceptions, partner 
interference, and not prioritizing HIV [Braksmajer et al., 2019]. In a study that looked at women 
who experienced IPV and were seeking care at a family planning clinic, PrEP barriers included 
limited awareness, misconceptions about PrEP, healthcare provider mistrust, HIV risk perceptions, 
concerns and fears of partner reaction and perceived short and long-term side effects [O’Malley et 
al., 2020]. Another study found that taking a daily pill could exacerbate an already unsafe situation 
in which relationship power is imbalanced and follow-up requirements every three months could 
be challenging [Willie et al., 2017].  
Several studies specifically examined PrEP barriers for Black women. In a study done among 
Black college age women, perceived barriers included cost, side effects, and taking the medication 
every day [Chandler et al., 2020]. Another study of Black women in the Bronx found that barriers 
included frequency of, and stigma associated with medical visits, and the burden of pill-taking for 
multiple health concerns [Collier et al., 2017]. Another study that interviewed Black women in 
Chicago found that women were concerned about PrEP side effects, stigma, cost, interactions with 
other medications and how PrEP affects fetal development [Hirschhorn et al., 2020]. Another study 
that looked at differences in PrEP interest between men and women found that women were less 
likely to perceive themselves to be at risk for HIV and that Black patients perceived their risk to 
be lower than white patients [Roth et al., 2019]. Lastly, a survey found that several barriers for 
 8 
Black individuals exist including low self-perceived risk, HIV conspiracy theories and mistrust of 
government, and lack of awareness that PrEP can prevent HIV [Ojikutu et al., 2018]. Study 
participants also expressed a greater interest in pills rather than other PrEP prevention methods 
being studied at the moment, such as vaginal gels or rings [Flash et al., 2014]. 
Several studies looked at barriers to use among FSW. Two studies found that oral PrEP as the 
only FDA approved biomedical prevention method is a barrier because in order to create more 
access, especially for FSW, there needs to be more diverse prevention options such as the vaginal 
rings or gels [Peitzmeier et al., 2017; Pines et al., 2019]. A study done in Zimbabwe found that 
FSW’s knowledge of PrEP is low, which prevents them from access since they are unaware of its 
existence [Mudzviti et al., 2020]. A study in China among 1,611 FSW found that while women 
were interested in PrEP, most participants had never heard of PrEP prior to study participation. 
[Peng et al., 2012].  
Existing literature also identifies barriers to PrEP use among AGYW. A study conducted in 
South Africa found that while most people involved in prescribing and implementation of PrEP 
think that AGYW need to use PrEP, the existing biases and power relations within these 
communities meant that they were unwilling to facilitate PrEP access [Nakasone et al., 2020]. The 
authors found that this was because of community norms around adolescent sexuality. In that case, 
PrEP providers viewed themselves as “guardians of youth health” and were fearful PrEP “would 
increase sexually risky behavior and divert drugs from those living with HIV” [Nakasone et al., 
2020, pg. 7]. Another study of young adults experiencing homelessness in the US found that 84% 
of participants were eligible for PrEP but only 66% perceived themselves at risk for HIV [Santa 
Maria et al., 2019]. The authors also highlight that current prescribing guidelines for PrEP focus 
on clinical monitoring protocols which leaves this group of individuals out of the conversation 
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because of their “lack of identification, lack of health insurance, low healthcare utilization, lack of 
jobs and therefore stable income, transportation needs, and unstable housing” [Santa Maria et al., 
2019, pg. 579]. Finally, among young people and adolescents at risk for HIV a common barrier 
was confidentiality when they are on their parent’s insurance [Moore et al., 2019]. 
Lastly, two studies, although not specific to a particular sub-group of women, identify barriers 
with implications for all women. A study in South Africa examined the relationship between 
depression, stigma, social support, optimism about PrEP and PrEP adherence. The authors found 
that depressive symptoms were common among women and were associated with lower PrEP 
adherence [Velloza et al., 2020]. Another study focused on engaging pregnant women in PrEP 
care found that if women were offered PrEP during pregnancy, they would use it [Seidman et al., 
2016]. However, they also found “gaps in screening and gaps in linkage to care before, during, 
and after pregnancy” [Seidman et al., 2016, pg. 632]. They noted that women who have just had 
children are more often lost-to-follow-up and because of this, miss opportunities for HIV 
prevention [Seidman et al., 2016]. 
2.5 Facilitators to PrEP Use Among Women 
Research examining facilitators to PrEP use has identified reasons that make PrEP easy to use 
or why people wanted to use it. Focus groups with Black and Latina women in New York 
highlighted four facilitators to use among study participants including insurance plan coverage of 
PrEP, PrEP will provide a contingency plan if condoms fail, PrEP reduces HIV incidence in the 
community, and learning that there are few side effects associated with taking PrEP [Collier et al., 
2017]. Clinical trial research provides evidence around facilitators of PrEP use and adherence 
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among women.  In the FEM-PrEP study, participants cited several reasons for adhering including 
personal motivations and adherence strategies [Corneli et al., 2015]. Another clinical trial, the 
HPTN 067/ADAPT Study, reported that the biggest facilitator to use was promoting a positive 
relationship between participants and study staff [Ojeda et al., 2019]. The authors suggest that 
providers make sure that they have an open dialogue and build trust with the patients and also 
understand the “social, political, economic, and historical factors that affect how patients view the 
providers and use the medication” [Ojeda et al., 2019, pg. 9]. 
Understanding facilitators across the entire  PrEP care continuum is essential to supporting 
women. A study exploring facilitators across the PrEP care continuum among women prescribed 
PrEP at an urban sexual health clinic found that factors motivating participants to seek out PrEP 
included “having a known HIV risk factor such as a sexual partner living with HIV, learning about 
PrEP through friends, or trusted providers” [Park et al., 2019, pg. 326]. They also found facilitators 
for linkage to “PrEP care, initiation, and continuation included positive interactions with informed 
and culturally competent staff, access to a discreet and convenient clinic, and insurance” [Park et 
al., 2019, pg. 326].  
2.6 Gaps That Currently Exist in Engaging Women in PrEP Care 
Existing literature provides important insight into PrEP care for women, though a number of 
gaps exist. The first is a lack of knowledge about HIV/PrEP among women. In a study that looked 
at a way to improve future PrEP interventions, a component of their theory was using observational 
learning, “which is behavior change from observing role models perform desired behavior”, they 
believe “this could increase knowledge of PrEP by improved outreach efforts, expanded 
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marketing, and educational activities by peers or other trust individuals” [Biello et al., 2018, pg. 
9]. Another study among heterosexual patients seeking care in a STI clinic found a perception of 
low risk among participants with the authors suggesting that PrEP use will likely remain low unless 
efforts are made to “improve risk perception, knowledge about PrEP, and safe sex methods” 
[Khawcharoenporn et al., 2012, pg. 231]. Studies specifically focused on Black women found that 
women were interested in using PrEP [Garfinkel et al., 2017] but were frustrated that PrEP is not 
being offered/advertised to them [Auerbach et al., 2015]. This contributes to a distrust of medical 
institutions among Black women since a prevention method exists but is not offered to them and 
they said it felt as though they were being left out of the conversation about something that can 
seriously impact them [Getty et al., 2018]. 
Women-centered advertising is necessary to support women’s awareness and uptake of PrEP. 
Women often report that they perceive PrEP to not be for them since it is not advertised to them, 
which may also have implications for women’s HIV risk perception [Hirschhorn et al., 2020; 
Nobles et al., 2020]. In a study among Black women in Chicago, participants who reported seeing 
PrEP advertisements found them not to be impactful as they were not targeting women in their 
communities and suggested three areas of improvement: (1) targeted advertising; (2) sharing 
information about PrEP through social networks, community events, and support groups; and (3) 
increasing PrEP-related communication among medical providers [28]. A study that looked at 
what role Instagram plays in risk perceptions and communication for PrEP found that when the 
term “#HIV” was searched the images that appeared were underrepresented people with high risk 
for HIV and very few images including Black women [Nobles et al., 2020].  
There is also a gap in providing culturally competent care. Some studies postulate that this is the 
reason that women, especially Black women, are not engaging in care. An article that looked at 
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social media to understand Black women’s perspectives on PrEP found that interventions aimed 
at Black women need to address concerns about safety preemptively because some women may 
be very concerned about side effects, especially their reproductive health [Hill et al., 2018]. 
Another aspect to culturally competent care is ensuring the right person is talking about PrEP. In 
a study that examined people’s trusted sources for PrEP information, the authors found that the 
majority of people identified some type of health provider [Jones et al., 2020]. Another study that 
looked at patient recommendations for PrEP information dissemination in Atlanta, Georgia, found 
that women wanted information about PrEP through educational materials and directly from 
family planning providers, and that clinics were the best sites for PrEP information [Sales et al., 
2019]. Another study among women at an urban obstetrics/gynecology (OBGYN) clinic in 
Philadelphia, Pennsylvania, found that most women felt it was important for the OBGYN or 
primary care provider to be the one to have the conversation about PrEP. However, it is important 
to note that 14% of the women were uncomfortable with the idea of talking to a provider about 
PrEP and “20% of the women were unsure if they would be comfortable” [Koren et al., 2018, pg. 
493]. While some studies found that women trust providers to talk to them about PrEP information, 
it is important to understand the impact of medical mistrust on women’s decision-making, 
especially among Black women. In a study that explored HIV-related mistrust and willingness to 
use PrEP among Black women, they found that knowledge and willingness to use PrEP was low, 
though when the conversation was shifted to empowerment women were more interested in PrEP. 
The authors suggest that “interventions that focus on empowerment through cultural or racial pride 
may help to increase uptake” in those communities [Ojikutu et al., 2020, pg. 2932].  
 13 
3.0 Methods 
This thesis uses multiple methods to understand the factors that influence women’s decision-
making process in taking PrEP, as well as to understand what interventions currently exist to 
support women’s PrEP use. Data for this thesis include existing qualitative interview transcripts 
(n=10) collected by STD-to-PrEP Demonstration Project, a longitudinal study investigating 
barriers and facilitators across the PrEP care continuum, and a rapid review of literature to identify 
PrEP intervention for women.  
3.1 Qualitative Interviews 
3.1.1 Data Source 
Data used in this qualitative analysis are from the ongoing STD-to-PrEP Demonstration Project 
collected from August 2020 onward by investigators from the University of Pittsburgh Graduate 
School of Public Health (mPI: Krier, Friedman). The STD-to-PrEP project is a demonstration 
project testing an intervention utilizing STI surveillance data to identify and engage individuals 
with high STI burden in accessing PrEP in Allegheny County, Pennsylvania. The project is done 
in collaboration with state and local health departments.  
 14 
3.1.2 Data Collection 
The Pennsylvania Department of Health (DOH) tracks reportable sexually transmitted infections 
(STI) diagnoses throughout the state using the Pennsylvania National Electronic Disease 
Surveillance System (PA-NEDSS). For the STD-to-PrEP demonstration project, a priority list of 
individuals with their fourth incident STI is shared with the Allegheny County Health Department 
(ACHD) HIV navigation staff for targeted PrEP navigation services. Navigation services involve 
discussion of PrEP as an HIV prevention option, referral to a PrEP provider if desired, referral to 
community-based resources, and introduction of demonstration project participation to those 18 
years of age or older. Contact information for interested individuals is shared with the University 
of Pittsburgh project team, which  proceeds with informed consent and project enrollment. Surveys 
and interviews over a six-month period assess PrEP care continuum, including decision-making, 
linkage-to-care experience, uptake, and discontinuation. Survey measures were selected based on 
established valid and reliable measures, and interview guides were designed to capture context 
around PrEP decision-making. Surveys are done electronically, and interviews are conducted over 
the phone. Following completion of surveys and interviews, participants receive electronic 
Amazon gift cards ($30-35) as a thank you for their time. The STD-to-PrEP Demonstration Project 
(STUDY19060124) was given a non-human subject designation by the University of Pittsburgh 
Institutional Review Board (IRB). 
3.1.3 Data Description 
The complete STD-to-PrEP Demonstration Project includes approximately 102 women and 
men. Data for ten women were used for this thesis. Informed consent was completed prior to the 
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phone interview, which was conducted by the University of Pittsburgh sexual health navigator and 
took 35 minutes. The interview included questions around HIV prevention/PrEP decision making 
process, PrEP uptake, and STI attitudes and decision-making. Participants were told that their 
name would not be included in the audio recording, they could decline to answer any questions, 
and could withdraw at any point in time. Interviews were audio-recorded and transcribed verbatim. 
Ten interview transcripts were purposively selected to include women across PrEP interest 
categories and included interviews with women who accepted a PrEP referral (n=3) or were still 
in the contemplation phase of deciding to take PrEP (n=7). No personal identifiers such as name, 
date of birth, phone number or email were included in the interview transcripts so that 
confidentiality could be maintained. Demographic information (i.e., age, race, ethnicity) of the ten 
participants was also shared. Of the ten women included, eight identified as Black non-Hispanic, 
one identified as White non-Hispanic, and one did not disclose race/ethnicity. The age of the 
participants ranged from 23 years old to 33 years old.  One participant did not share age data. The 
average age of the nine participants that provided age was 27. Before beginning the analysis of the 
interviews, an IRB application (STUDY21020114) was submitted and was exempt from IRB 
approval as it was given a nonhuman research designation.  
3.1.4 Analysis 
Interview transcripts were managed and analyzed in Dedoose, a web-based qualitative data 
management software. In order to effectively analyze the interviews, a form of grounded theory 
method was used [Foley & Timonen, 2015]. Geraldine Foley and Virpi Timonen describe 
grounded theory as “a systematic set of techniques and procedures that enable researchers to 
identify concepts and build theory from qualitative data” [2015, pg. 1197]. The larger purpose of 
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this theory is to identify and explain how and why people behave in certain ways [Corbin & 
Strauss, 2008].  
There are three stages in coding: initial, intermediate, and advanced [Chun et al., 2019]. Initial 
coding is used to start breaking up the data to compare different experiences looking for similarities 
and differences [Chun et al., 2019]. This coding is done by understanding what the participants 
say they are “doing, feeling, and being” [Foley & Timonen, 2015]. Once categories begin to 
develop, intermediate coding begins and involves the formation of abstract concepts and the 
refinement of core categories[Chun et al., 2019]. The purpose of this stage is to get a better idea 
of what is happening in the data [Chun et al., 2019]. The third and final stage of coding is advanced 
coding. In advanced coding the researcher is attempting to identify a theory. Birks and Mills 
proposed a storyline technique to assist in this stage of coding. They define storyline as “a strategy 
for facilitating integration, construction, formulation, and presentation of research findings 
through the production of a coherent grounding theory” [Birks & Mills, 2015, pg. 180]. This 
process builds a story that helps to draw a line between all the categories identified [Chun et al., 
2019]. 
Throughout the process of coding, one of the most important tools to use is memo writing. In 
Chun et al.’s articles, they state that memos are meant to detail “why and how decisions were made 
related to sampling, coding, collapsing of codes, making of new codes, separating codes, 
producing a category, and identifying relationships abstracted to a higher level of analysis” [2019, 
pg. 4], referencing the work of Birks and Mills [2015].  
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3.2 Literature Review 
3.2.1 Search Strategy 
To contextualize the qualitative interview analysis, a rapid review identified existing peer-
reviewed published literature focused on interventions engaging women in PrEP care. Relevant 
literature was identified through a combination of terms related to PrEP, women, and intervention. 
Appendix A outlines the full Medline search. The search was conducted in November 2020 and 
was changed slightly to get a more targeted search for articles that specifically mentioned women. 
All publication dates were considered for inclusion. Helena VonVille, a Research and Instruction 
Librarian at the University of Pittsburgh’s Health Sciences Library System, provided input and 
guidance regarding the search strategy. An initial title and abstract screening ensured selected 
studies broadly reflected inclusion and exclusion criteria. Full text documents of articles meeting 
inclusion criteria were then obtained and reviewed for final eligibility. 
3.2.2 Inclusion Criteria 
Articles included met the following criteria: (1) PrEP focused; (2) cisgender women; (3) 
intervention focused; (4) peer-reviewed; and (5) written in English. Articles were excluded if they:  
(1) the majority of the sample were transgender women, transgender men, men who have sex with 
men, or cisgender men; (2) included HIV-positive participants; (3) did not focus on an intervention 
to promote uptake, adherence, or compliance to PrEP; (4) were not an original study; (5) included 
participants of doctors/pharmacists/students/etc.; (6) were not a study about PrEP; and (7) other 
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(e.g., PrEP was only a small portion of the study’s focus, the study was not completed yet, and 
information about improving clinical trial adherence that was not generalizable). 
3.2.3 Data Extraction and Analysis 
The full set of articles was reviewed to understand women’s interest in PrEP, barriers to use, 
facilitators to use, interventions that currently exist, and suggestions for potential interventions. 
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4.0 Results 
4.1 Qualitative Interview Findings 
Results of the analysis conducted with data from the interviews with women in the STD-to-PrEP 
Project (n=10) revealed the decision-making process that women go through when determining 
whether they should take PrEP. In the end, the core category was decision-making influences and 
there were five sub-categories: 
1. HIV, PrEP, and STI Knowledge 
2. Stigma and Risk Perception 
3. Barriers to PrEP Use 
4. Facilitators to PrEP Use 
5. Women’s Preferences for PrEP Outreach 
A total of 28 codes were organized into the five sub-categories. Each of these codes and 
categories offered insight into the women’s decision-making process and factors that influence 
women’s decision-making process for taking PrEP (see Figures 1 and 2 below for a breakdown of 
the coding process). The following sections will discuss codes in each sub-category and how the 




Figure 1. Chart of Core Category and Subcategories 
 
Figure 2. Chart of Codes within the Subcategories 
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4.1.1 HIV, PrEP, and STI Knowledge 
HIV, PrEP, and STI knowledge included codes such as HIV knowledge, PrEP knowledge, and 
prevention methods. The definitions for these codes can be found in memo 1 in Appendix B.  
When reporting HIV prevention methods, respondents described their use of condoms, 
abstinence, and/or HIV testing. Women spoke about ensuring that their partners were tested before 
they became intimate or deciding to forego condom use. HIV knowledge was present throughout 
the interviews in that participants understood that HIV risk increases when having multiple sex 
partners. However, there were misconceptions about HIV risk. One woman assumed that everyone 
who has HIV is medicated for it.  
While knowledge about STIs was evident in this sample of women, knowledge about HIV and 
HIV risk perception was low. The following quote elucidates an important point within this sample 
of women. A woman spoke about being more worried about STIs than HIV because “you won’t 
come across HIV more than chlamydia or I guess gonorrhea or anything like that.” While  It is 
possible that this does not show a lack of knowledge about HIV or HIV risk, but a well-informed 
personal risk benefit analysis, the distinction between HIV and STI worry is important to note.  
There were also a large number of questions that were asked particularly about side effects of 
PrEP and how it provides protection. With that being said, most women knew that generally PrEP 
was for HIV protection.  
Lastly, the women did note that they thought it was for “gay couples” because of the 
advertisements they had seen for PrEP. It was also noted in an interview that spoke about 
commercials for PrEP that “nobody brings it up because this is the first time hearing it. I only saw 
commercials about it, but not in a physician, never. Even with my annual gynecologist visits, they 
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don’t really- it’s always birth control, never STD or STI prevention.” While STI knowledge was 
evident in this sample of women, knowledge about HIV and HIV risk was low.  
4.1.2 Stigma and Risk Perception 
Codes for this category included risk perception, STI concerns, stigma, HIV risk, barriers to 
prevention methods, and facilitators to prevention methods. The definitions for these codes can be 
found in memo 1 in Appendix B. 
Content in this category made it clear that these women understood HIV risk behavior, most 
often citing having multiple sexual partners. In some of their answers, there was a level of stigma 
associated with HIV was demonstrated in that they were very insistent that they were not 
participating in behaviors that would put them at risk for HIV. One woman said, “I’m not really 
concerned because I don’t put myself out there like that.” Another woman stated, “I am only 
sleeping with one person, and I think it’s for people who have multiple sexual partners.”  Lastly, 
a woman stated, “I kind of just don’t think that PrEP is for me but maybe other people that are 
more out there, more sexual.”. They had an understanding of risky behavior but did not associate 
their multiple STIs with risk.  
Three of the ten women in this cohort acknowledged some level of HIV risk by agreeing to take 
PrEP, but seven of the other women said they have never been concerned about HIV and that they 
do not view themselves at risk. For example, when one woman was asked if she has ever felt 
concerned about her risk for HIV she responded “No, because I feel that I’m not doing at-risk 
behaviors to get HIV.”. Another participant stated: 
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I’m not too concerned because I haven’t really had sexual intercourses with anybody. And when 
I do, they’re not new partners for the most part. They’re always the same people. But then because 
you don’t know who they’re having sex with, so that becomes a problem as well because they could 
be having sex with somebody that HIV-positive, and we don’t know, and they come back and have 
sex with me. 
Content in this category can be closely associated with HIV, PrEP, and STI knowledge because 
less knowledge about those subjects can create lower risk perceptions. Women were also asked 
about barriers and facilitators to prevention methods. Most of the women said that condoms were 
their form of prevention against HIV and STIs, but then said things like “alcohol”, “getting caught 
up in the moment”, and “not liking the feeling” are barriers to prevention methods, particularly 
condoms.  
Perhaps the most powerful quote in this interview analysis speaks about stigma and possible 
intervention opportunities for educating about HIV and PrEP:  
Is there any way that- I don’t know how to word it. All right. So it’s like a lot of people have this 
stigma about HIV where it’s like, ‘Oh if I hug you, I will catch it. If I kiss you, I will catch it. If 
you’re positive, I’ll automatically catch it’. However, like I said, one of my closet friends has it , 
and she has taught me so much about the disease and I’m like ‘Wow. It’s amazing that we’re not 
taught these things ahead of time. 
4.1.3 Barriers to PrEP Use 
Barriers to PrEP use included interview codes such as PrEP concerns, PrEP refusal reasons, 
providers not talking about PrEP, remembering to take the pill, side effects, medication use, 
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medication interactions, other disease interactions, and place they have seen PrEP. The content 
related to these codes gave insight into what barriers exist for women in Pittsburgh, Pennsylvania, 
and taking PrEP. For definitions of these codes, see memo 1 in Appendix B.  
In general, women have a lot of concerns about how PrEP impacts other aspects of their life 
such as their other illnesses. One woman asked, “If you have diabetes or maybe high blood 
pressure or something does it affect you differently?” Another woman was concerned about how 
it might interact with respiratory illnesses and polycystic ovary syndrome (PCOS).  
Remembering to take the pill and side effects were the most common barriers to PrEP use among 
this sample of women. They often commented that they had other medications they are supposed 
to take daily already, and they cannot remember to do that so they would definitely not remember 
to take PrEP every day. One woman asked how often PrEP was taken and when informed that it 
was a daily medication, the woman replied “Yeah. I can’t even remember to take a birth control 
pill.”  Another woman said: 
I don’t take pills, so that would be difficult, me remembering to take that every single day. That’s 
why I don’t take birth control, because I mess it up. I don’t know. I can’t take pills on the regular. 
I’ve never had to. So, me just doing it out of the blue, it becomes a problem.  
Several respondents cited potential side effects as a barrier to PrEP uptake (n=9). Most people 
referenced not wanting to experience any side effects as they are especially sensitive to medication 
side effects, one woman claiming: 
I don’t think my body is going to have a good reaction to it. I’m allergic to most antibiotics too, 
so I have reactions to that. So, imagine me taking just a random-kind of, I guess it’s kind of like 
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birth control but not like a birth control, it just kind of stops- not stops you, but prevent you from 
getting it. I just think my body’s not going to react to it good. 
 Others were genuinely curious about the side effects as they were unsure of what side effects 
were associated with PrEP. In one instance, the interviewer asked if there are any other challenges 
to PrEP other than taking it every day; the woman responded, “No, other than if there are side 
effects.”  When women were asked why they would not take PrEP, variety of responses were 
observed in addition to what has already been mentioned including: needing more information to 
feel comfortable making that decision, not considering themselves at risk for HIV at the time of 
the interview, not being concerned about their HIV risk at all, and thinking that once you start the 
medication, you have to take it forever.  
4.1.4 Facilitators to PrEP Use 
Facilitators to PrEP use included interview codes such as PrEP motivation, PrEP navigator, 
comfortability talking about PrEP, PrEP positives, support from providers, support from 
family/friends/significant others, support in taking PrEP, intention to use PrEP, medical trust, 
trusting family and friends, and trusting health providers. The definitions for these codes can be 
found in memo 1 in Appendix B.  
The most common answer when women were asked about the pros of PrEP was that it can 
prevent HIV. The amount of trust these women have for their medical care providers is particularly 
striking. In every interview the women cited trusting their providers, specifically their 
gynecologists and obstetricians. This was most often in response to the questions; “who are people 
you trust to learn about health from?” and “who are people you trust to talk about your sexual 
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health and HIV prevention?” Others also cited trusting their friends, family, or significant other in 
regard to these same questions, but those who cited providers were in the majority. Another aspect 
of this category was how women could be supported in their PrEP use. Women typically said that 
frequent visits with medical providers, having an alarm to remind them to take the pill, having the 
resources to do their own research on PrEP, and support from significant others would support 
their PrEP use. Further, being armed with information about PrEP, understanding HIV 
epidemiology in their area, having PrEP navigators to help them through the process, having some 
training on how to talk to their partners about PrEP, and if it were a once a month or even once a 
week pill rather than daily would be helpful in supporting their PrEP use.  Lastly, an important 
aspect of PrEP facilitation is understanding how comfortable women felt talking about it and in 
this specific subset, women said they would feel comfortable discussing PrEP with their providers 
or a PrEP navigator and preferred that the conversation took place face-to-face.  
4.1.5 Women’s Preferences for PrEP Outreach 
Content related to this category allowed for understanding how women can be more comfortable 
when contacted for PrEP initiation. The interview codes for this category included health 
department follow-up feelings and study reactions. Definitions of these codes can be found in 
memo 1 in Appendix B.  
Women’s reactions to health department follow-up were mixed. They ranged from dislike to not 
minding. One woman said, “I thought it was kind of- I don’t remember signing anything to release 
my information, so I was kind of surprised, but I didn’t mind.” Another woman said, “Yeah I didn’t 
care. It didn’t bother me.”  On the other hand, one woman said, “It was okay. I just prefer to be 
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notified when I’m about to get those type of calls, so I know to step outside if I’m at work or 
something.”  Lastly, other women described being upset, for instance: 
I kind of didn’t like it. I felt like my privacy was- I know it’s something they got to tell, but I felt 
like it’s a lot that- I felt like that was a personal, private thing that I didn’t like. I don’t like that. I 
know that somebody got to-they got to report them, but yeah, for me, personally, that’s something 
I don’t like. Like I said, me, personally, I don’t talk about my sexual life unless it’s with my sexual 
partner or doctor. So, yeah, it’s kind of embarrassing and a little shameful. 
4.2 Literature Review Findings 
The rapid review yielded 675 articles eligible for preliminary screening; of those, 123 underwent 
full-text screening and 59 were deemed eligible for review inclusion. Of those 59 articles, only 
five were intervention focused. The other 52 articles served as background. This points to the lack 
of intervention strategies present. Few women-centered interventions exist to support women’s 
uptake and adherence to PrEP. The interventions that do exist ranged from educational videos to 
multi-level programming. The first article discussed the results of piloting an intervention that was 
a video about post-exposure prophylaxis (PEP) and PrEP. They found that of their sample, “89% 
rated the video as good or better” [Bond & Ramos, 2019, pg. 7]. The regression for the data was 
done, it was found that factors relating to higher scores for the video were “not engaging in any 
current drug use, using condoms all the time in the past 3 months, higher household income, lower 
education level, and less experience of sexual abuse as an adult” Bond & Ramos, 2019, pg. 7].  
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Similarly, another article evaluated a computer-based training program to teach adults who at 
risk for HIV about PrEP. The study was targeted towards teaching PWID about HIV and PrEP. 
The program modules contained educational material and multiple-choice questions. The 
participants received immediate feedback for responses and incentives when they answered 
correctly. The modules were divided into three parts, the first about HIV, the second about PrEP, 
and the third about HIV risk behaviors. The study found that HIV and PrEP knowledge increased 
following the completion of each module [Getty et al., 2018].  
The next article was also technology-based. This study “adapted an SMS platform to send PrEP-
tailored, theory-based SMS that also allowed for clients to communicate with a remote nurse” 
[Pintye et al., 2020, pg. 55]. The study found that the texts “expanded support for PrEP and created 
additional opportunities for women to have a dialogue about PrEP outside a clinic setting” [Pintye 
et al., 2020, pg. 55]. The women were able to ask questions and get answers in real time about 
their PrEP use and that was found to be a big facilitator to use [Pintye et al., 2020].  
One article looked to address the issue of messaging around PrEP. This article discussed the 
process for creating a palm card that had information about HIV prevention and PrEP. A palm card 
is typically a small card that lists brief, relevant information on a certain topic. The authors tested 
the card among experts and community members who found the card to be “informative and 
potentially motivational” [Collier et al., 2018, pg.13]. The majority of the reviewers said that it 
served as motivation to start engaging with a healthcare provider to get more information or access 
to HIV prevention and at the very least motivate women to start having conversations with sexual 
partners about risks [Collier et al., 2018].  
The last article looked at discussed the intervention called CHRP-BB (bio-behavioral 
community-friendly health recovery program). This is an intervention for opioid-dependent people 
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who use drugs. The intervention has several steps. The first is that individuals were screened for 
eligibility and if eligible, they were referred for additional screening to be prescribed PrEP. Those 
who initiated PrEP are part of the study. The intervention is a manual guided intervention 
comprised of four, 50 minute weekly group meeting that address HIV risk behaviors and PrEP 
adherence among high risk people who use drugs in treatment [Shrestha et al., 2019]. The groups 
were led by trained facilitators. The material for the groups were given using three modalities: 
verbal, visual, and experiential. The groups were taught content relating to drug and sex related 
HIV risk reduction, PrEP basics, motivation to encourage PrEP use/adherence, problem solving 
skills, facilitators of PrEP adherence, enhancing decision-making related to PrEP, and overcoming 
stigma [Shrestha et al., 2019]. The intervention also included daily texts where participants 
received PrEP reminders. The intervention was found to be effective, retention was high 
throughout the intervention, and attitudes towards the program were positive [Shrestha et al., 
2019]. These interventions are summarized in Table 1. 
 
Table 1. Women-centered PrEP Interventions 
Intervention Name Method of Delivery Key Components Important Notes 
PEP and PrEP Video 
[Bond & Ramos, 
2019] 
Video An educational video 
about PEP and PrEP. 
Does not seem geared 
towards those most at 
risk Highest scores 
were from those who 
did not use drugs and 
reported always using 
condoms 
HIV and PrEP [Getty 
et al., 2018] 
Computer training 
program 






All PWID were in 
methadone treatment 
centers when training 
was completed, this 
might not be 




not ready for 
treatment. 
SMS Platform 
[Pintye et al., 2020] 
Cell phone The program allowed 




for women to ask 
questions and get 
answers in real time. 
The study was done 
in Kenya; however, 
this could help to 
alleviate barriers with 
women because the 
prevention specialist 
would be able to 
immediately address 
any concerns at the 
time of taking PrEP. 
PrEP Messaging 
[Collier et al., 2018] 
Palm Card  The card contained 
information about 
HIV prevention and 
PrEP that providers 
could take into 
appointments with 
patients to provide 
motivational 
information. 
The card was tested 
among experts and 
community members 
who found the card to 
be informative and 
motivational enough 
to start engaging with 
the healthcare 
provider to get more 
information or at 




et al., 2019] 
Weekly group 
meetings/cell phone 
This intervention is a 
manual guided 
intervention 
comprised of four, 50 
minute weekly group 
meeting that address 
HIV risk behaviors 
and PrEP adherence 
among high risk 
people who use drugs 
in treatment [Shrestha 
et al., 2019]. 
The treatment was 
found to be effective, 
retention was high, 
and attitudes towards 
the program were 
positive. However, 
the PWID were in 
treatment once again 
so this may not be 
appropriate for 
someone who is not 
ready for treatment. 
Table 1 Continued 
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5.0 Discussion 
The qualitative analysis of interview data revealed many gaps in the current PrEP care provided. 
The comprehensive review of literature pointed to lack of comprehensive, flexible women-
centered PrEP interventions. The results of this thesis show that women w face many barriers to 
using PrEP as an HIV prevention strategy and that addressing those concerns and providing 
effective solutions will require individualized approach.  
While the literature review demonstrated that in general women were interested in taking PrEP, 
aside from women who experience IPV, where the interest was mixed [Carley et al., 2019; Kuo et 
al., 2016; Kwakwa et al., 2016; Peitzmeier et al., 2017; Rubtsova et al., 2013; Taggart et al., 2020; 
Willie et al., 2020], the content analysis of the ten interviews shows that PrEP interest for women 
in Pittsburgh, PA is low. A Of the ten interviews analyzed for this study, only three of those ten 
were interested in PrEP use and starting PrEP.  
The literature indicated that the major barriers for women taking PrEP were poverty, 
incarceration, unemployment, distrust of providers and locations where HIV prevention services 
are offered, dislike of condom use, IPV, challenges related to gendered power, cultural issues, 
stigma associated with HIV and women’s sexual behavior, and a lack of intervention strategies 
that address risk across multiple levels [Abrams et al., 2020]. These barriers were identified and 
contextualized in women’s discussion of HIV and HIV risk in the interviews. Women’s perception 
of HIV risk varied by participant and a distinction between STI risk and HIV risk offers important 
leverage point for education efforts. The interview also highlighted that significant stigma still 
exists related to HIV and women’s sexual behavior. Furthermore, women expressed concerns over 
 32 
medicinal cross-reactions with PrEP and the potential impact on other chronic illnesses. They were 
also very concerned with daily dosage of PrEP and the side effects associated with PrEP. This 
informs researchers that PrEP knowledge and HIV knowledge are low in this cohort of women. 
This is further elucidated in the interviews when participants were asked about what they knew 
about PrEP and they were not sure.  
The literature demonstrated that facilitators to PrEP use among women included PrEP being 
covered by insurance plans, PrEP as a good contingency plan if condoms fail, PrEP reduces HIV 
incidence in the community, and lastly, learning that there are few side effects associated with 
taking PrEP [Collier et al., 2017], as well as personal motivations and adherence strategies [Corneli 
et al., 2015]. The interview analysis reflects those same facilitators to PrEP use among women. 
Protection from HIV was a critical facilitator for PrEP use in relation to condom failure or not 
using condoms; having reminders to take the pill were also cited, and having support from family, 
friends, or their significant other. However, an area where the most difference was found is the 
level of concern for side effects. Once the interviewer explained what the side effects were, that 
did not change how women perceived the risk of them. They were still hesitant to use PrEP after 
learning the side effects. While there are few side effects, it is important to consider how the 
severity of those side effects impacts women’s decision-making.  
Several articles in the rapid review of intervention literature provided recommendations to 
improve PrEP engagement among women, which included using theories or models [Adams et al., 
2020; Biello et al., 2018; Roth et al., 2019; Shrestha et al., 2017]. Of these, the Information-
Motivation-Behavior Skills model offers great potential for PrEP intervention development for 
women. The results from using the model found three components for interventions to target 
specifically for people who use drugs: (1) Understanding PrEP-related information like 
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effectiveness, side effects, adherence, perceived affordability, and risk compensation; (2) Personal 
motivation like acceptability, anticipated HIV stigma, safe sex initiation, safe drug use practices, 
perceived and controlled risk of HIV and social motivation like prevention altruism, peer values 
and medication use, peer sex and drug use norms, dyadic decision making; (3) The development 
of practical behavioral skills in adhering to PrEP medications, managing side effects, negotiating 
PrEP use, sustaining motivation, and safe sex drug use practices in the context of PrEP [Shrestha 
et al., 2017]. Although this model was specifically referencing use of PrEP by women who inject 
drugs, the general areas they focus on for an intervention are applicable in the interview cohort.  
The interviews found that women did not have a clear understanding of what exactly PrEP is 
including its effectiveness, side effects, adherence, perceived affordability, and risk compensation. 
The women also expressed concern about not being able to adhere to PrEP because they had to 
remember to take the pill daily or they lacked an adequate social support system. This model could 
be useful in combating the barriers that were seen in this specific cohort.  
Another area for improvement found in the literature was providing culturally appropriate care 
and to that extent changing the target audience for PrEP advertisements. The literature suggested 
understanding who these women trust to receive information from [Park et al., 2019] and  how 
relationships play a role in PrEP decision-making, especially in regard to IPV [Atkins et al., 2010; 
Holmes et al., 2020; Willie et al., 2017; Willie et al., 2019]. The interview analysis found that a 
large majority of these women trusted their medical provider to give them health information or 
sexual health information. This was inconsistent with what the literature cited. The literature 
alleged that women, especially Black women, have a history of provider mistrust which needs to 
be considered in engaging them in care. It is important to note that eight out of the ten women 
were Black women.  
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To that end, for this cohort it could be useful to examine how providers engage these specific 
women in care that results in greater trust as compared to other medical providers giving PrEP 
care. However, it is important to consider that some of the women also considered family, friends, 
and/or significant others as trustworthy sources of information. Further, in the interviews, several 
women spoke about the importance of their significant others or family members and their reaction 
to starting PrEP. This supports the notion that women need to be seen as more than just an 
individual in addressing the appropriate approach to care. Their social and familial support systems 
should also be taken into account to better engage them in care. If providers listen to patients’ 
concerns and respond to them accordingly, they might build trust with the patient.  
In regard to PrEP messaging, the literature talked about meeting women where they were, 
especially in regard to injection drug use. Advertising PrEP in places such as “syringe exchange 
sites, naloxone distribution programs, opioid substitution therapy sites, and in emergency rooms 
or clinics” [McFarland et al., 2020, pg. 1292] would be beneficial. This was further supported by 
the interview analysis. The women spoke about not seeing themselves represented in PrEP 
commercials or billboards and therefore they did not think it was an option for them. The lack of 
representation of women in PrEP advertising has potential to contribute to misinformation about 
PrEP and HIV risk among women. 
The most significant area of improvement for current interventions needs to be in HIV risk 
perception and knowledge of PrEP. This was highlighted in the form of doctor’s recognizing and 
talking about risk, as well increasing HIV knowledge through education. Providers can identify 
patients at risk such as through the use of electronic health records [Krakower et al., 2019; Ridgway 
et al., 2018; Tomko et al., 2019] and further providers need to understand how changes in perceived 
risk by the person can influence their willingness to take PrEP [Lankowski et al., 2019]. These 
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articles highlight the opportunity for healthcare providers to continually assess and educate HIV 
risk because it can fluctuate with time. The model of care needs to be more flexible in order to 
continue to engage people in PrEP [Lankowski et al., 2019]. Other areas of the literature focused 
on the lack of knowledge surrounding HIV and PrEP, one finding that men had a higher initiation 
rate which was associated with previous knowledge [Kwakwa et al., 2018]. Another study found 
that women would be more willing or likely to take PrEP if they were informed about HIV 
epidemiology in their area [Kwakwa et al., 2016].  
Lastly, the literature spoke about integrating PrEP counselling, education, and HIV risk 
awareness education into clinic appointments [O’Connell et al., 2020; Park et al., 2019; Taggart et 
al., 2020] and how this would increase HIV and PrEP knowledge. Each of these points were 
evident in the interview analysis. One woman spoke specifically about how she would take PrEP 
if HIV prevalence was higher in her community. Further, in the interview analysis, women talked 
about their lack of knowledge and exposure to information to PrEP, even from their doctors. 
Additionally, most women expressed low or no concern for HIV risk, which may not be accurately 
represent their risk of exposure to HIV. By implementing education for HIV and PrEP in clinics 
or doctors’ offices, women will have more information and tools to support decision-making 
around HIV prevention and PrEP. While this type of education would ideally begin in high school, 
healthcare settings have great potential to serve as crucial sites for STI and HIV prevention and 
education. 
A shortcoming of three out of the five intervention methods from the literature is that they were 
geared towards PWID. That is suboptimal because it illustrates that these interventions are not 
targeting those most at risk, as these people were in treatment already. These samples, therefore, 
may not be representative of those not ready for treatment for substance use disorder. This also 
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means the findings may not be as applicable to women who do not have substance use disorder. 
However, the important aspects of those three interventions are that educational videos can be 
effective, especially those that provide immediate feedback, and even further that interventions 
such as the CHRP-BB model can be implemented and be successful. These interventions should 
be applied to different at-risk populations and evaluated for effectiveness.  
The other two interventions are the most directly relevant to the outcomes of the interview 
analysis. The first was the SMS platform [Pintye et al., 2020], which given the analysis of the 
interview and women being concerned about remembering to take the pill, would be potentially 
effective. As technology evolves and becomes an increasingly important part of our world, it needs 
to be part of PrEP prevention strategies. This would make confronting barriers and promoting 
facilitators of PrEP much easier if prevention specialists could do them in real time as they are 
presented to the user. Secondly was the PrEP messaging intervention with the creation of the palm 
card [Collier et al., 2018]. This would be useful as researchers suggest that providers should be 
having this conversation with women to help them understand their HIV risk and educating on 
PrEP. It can be used as a model to guide the creation of other palm cards or more educational 
materials that providers can use to facilitate productive conversations with women. 
Clear gaps exist in the current care being provided to women in regard to PrEP. Several already 
existing interventions could be combined to create an effective approach, but the most important 
components of any future intervention are as follows: First, educating women about their HIV risk 
and PrEP any chance that is available. Whether in clinics, providers’ offices, or treatment centers, 
providing information is key. The palm card would be an appropriate addition in this step to help 
providers get clear, concise information to women in an effective way. Additionally, listening to 
what women have to say about their own barriers and what would help them to stay adherent to 
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PrEP, whether that is through interviews or surveys, can be useful in continuing to improve these 
outreach attempts. Women are the experts in topics regarding their own needs and health. Further, 
providers should work alongside women to develop adherence strategies. PrEP navigators are 
crucial for this approach, as well as the development of the SMS platform. It is incredibly important 
to understand who they are in the bigger picture, what relationships they have that would make 
PrEP uptake and adherence more or less difficult. If they feel like their provider or navigator 
understands them and wants to help them navigate their particular barriers, they will be more 
willing to work through them and stay adherent to PrEP.  
There were two limitations to this review. The first is that the interview analysis occurred in a 
small cohort of women, so that generalizing the results to women as a whole is not possible. The 
second limitation is that there was only one coder. This was due to the time constraints on the 
project.  
While these are limitations exist, the strength of this study is that the interviews were done with 
women who would be logical targets for PrEP. The interview participants provided incredible 
insights on barriers, facilitators, attitudes, knowledge, and broadly decision-making influences on 
PrEP. Further, they showed in their answers ways in which public health practitioners can address 
some of the biggest failings in current HIV prevention interventions, as well as use some of the 
strengths of current interventions.  
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6.0 Conclusions 
Women have largely been ignored in efforts for PrEP provision, although it has potential to be 
an ideal prevention strategy. While women represent 19% of new HIV cases, in 2018 only 7% of 
PrEP users were women. Despite there being nearly one million people who benefit from PrEP, 
uptake is low, especially in women. In order to better understand this problem, this thesis explored 
how women in Pittsburgh, Pennsylvania, describe their PrEP decision-making processes, barriers, 
and facilitators to PrEP use and what current interventions exist to engage women in PrEP care 
through a rapid review of the literature. 
The result of the literature review and interview analysis suggest that women face many barriers 
to using PrEP and that addressing those concerns and providing effective solutions will take an 
individualized approach. Women have a lot to say about using PrEP, what they feel are barriers 
and facilitators, and ways in which PrEP providers can improve. It is imperative that we listen to 
what these women have to say if we want to increase PrEP use among this population. Women are 
diverse and sometimes different approaches will be needed, but it is clear that a one size fits all 
approach is not effective.  
In summary, the most important aspects of a good PrEP intervention are educating women about 
their HIV risk and PrEP at any available moment, listening to what women have to say about their 
own barriers and facilitators to PrEP use, and creating adherence strategies with them. What seems 
to be lacking in current interventions is the incorporation of women in the design. In public health, 
there is often an approach to program planning where the researcher feels they know what is best. 
Those interventions are the ones that tend to not work because it did not consider the perspective 
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of the community. In short, including the community in which you are intending to impact in the 
design of the program, will likely make it more successful. 
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Appendix A Literature Review Search 
Search line # Search Query 
1 Pre-Exposure Prophylaxis/ 
2 (prep or Pre-Exposure Prophylaxis or (preexposure adj1 
prophylaxis)).ti,ab,kf,rn. 
3 ((emtricitabine and tenofovir) or DESCOVY or microbicide* or truvada or 
(vaginal adj1 ring)).ti,ab,kf,rn. 
4 Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/ or 
Emtricitabine/ 
5 1 or 2 or 3 or 4 
6 HIV/ 
7 hiv infections/ or acquired immunodeficiency syndrome/ 
8 (((acquired or human) adj2 immunodeficiency) or aids or hiv).ti,ab,kf. 
9 6 or 7 or 8 
10 5 and 9 
11 women/ or pregnant women/ or female/ 
12 (women or female* or girls).ti,ab,kf. 
13 11 or 12 
14 10 and 13 
15 evaluation studies/ or "evaluation studies as topic".pt. or program evaluation/ 
or validation studies/ or "validation studies as topic".pt. or (effectiveness or 
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intervention or (pre- adj5 post-) or (pretest adj5 posttest) or (program* adj6 
(evaluate or evaluated or evaluates or evaluating or evaluation or evaluations 
or evaluator or evaluators))).ti,ab,kf. 
16 Counseling/ or Directive Counseling/ 
17 counseling.ti,ab,kf. 
18 health knowledge, attitudes, practice/ or "patient acceptance of health care"/ 
or patient compliance/ or medication adherence/ or treatment refusal/ 
19 Health Promotion/ 
20 15 or 16 or 17 or 18 or 19 
21 14 and 20 
22 21 not ((exp africa/ or exp asia/ or exp australia/ or exp canada/ or exp central 
america/ or exp europe/ or exp south america/) not ((exp africa/ or exp asia/ or 
exp australia/ or exp canada/ or exp central america/ or exp europe/ or exp 
south america/) and (north america/ or exp united states/))) 
23 limit 22 to yr="2012 - 2021" 
24 23 and english.la. 
25 "systematic review".pt. or "Systematic Reviews as Topic"/ or (data adj2 
(extract or extracting or extractings or extraction or extraction)).ti,ab,kf. or 
((cochrane adj2 database adj2 systematic adj2 reviews) or (evidence adj2 
technology adj2 assessment)).jn. or (((comprehensive* or integrative or 
mapping or rapid or scoping or systematic or systematical or systematically or 
systematicaly or systematicly or umbrella) adj3 (bibliographical or 
bibliographically or bibliographics or literature or review or reviews)) or (state 
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adj3 art adj1 review) or (research adj2 synthesis) or ((data or information) adj3 
synthesis)).ti,ab,kf. or ((review adj3 (rationale or evidence)).ti,ab. and 
"review".pt.) or (cinahl or (cochrane adj3 (trial or trials)) or embase or medline 
or psyclit or (psycinfo not (psycinfo adj1 database)) or pubmed or scopus or 
(sociological adj1 abstracts) or (web adj2 science)).ab. or "Meta-Analysis".pt. 
or "meta-analysis as topic"/ or "network meta-analysis"/ or ((meta adj2 
(analyse or analyser or analyses or analysis or analytic or analytical or 
analytics or analyze or analyzed or analyzes)) or metaanalyse or Metaanalysen 
or metaanalyser or metaanalyses or metaanalysis* or metaanalytic or 
metaanalytical or metaanalytics or metaanalyze or metaanalyzed or 
metaanalyzes).ti,ab,kf. 
26 10 and 20 and 25 
27 26 not ((exp africa/ or exp asia/ or exp australia/ or exp canada/ or exp central 
america/ or exp europe/ or exp south america/) not ((exp africa/ or exp asia/ or 
exp australia/ or exp canada/ or exp central america/ or exp europe/ or exp 
south america/) and (north america/ or exp united states/))) 
28 27 and english.la. 
29 24 and 28 
30 28 not 29 
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Appendix B Grounded Theory Memo 1 
Memo #1 
2/27/21 
The first round of open coding is done. I ended up with 28 codes. Below are the codes and their 
definitions: 
1. ACHD Follow-up feelings: This was anytime that the person spoke about the phone call from the 
health department 
2. Comfortability talking about PrEP: Situations in which the person described a situation where they 
would be comfortable talking about PrEP 
3. HIV Knowledge: This is their knowledge of HIV  
4. HIV risk: This is their understanding of what HIV risk looks like in other people 
5. Intention to use PrEP: This is when they explicitly say that PrEP is right for them 
6. Medication Interactions: This is when they ask questions or express concern about how PrEP interacts 
with other medications 
7. Medication use: This is when they are talking about taking the pill every day and they express that they 
already use a daily medication 
8. Other disease interactions: This is when they ask questions about or express concerns about how PrEP 
would affect their other illnesses 
9. Places they have seen PrEP: Places where PrEP has been advertised 
10. PrEP Knowledge: This is their knowledge about PrEP 
11. PrEP Motivation: This is when they express something that would motivate them to take PrEP 
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12. PrEP Navigator: This is when they express that something like a PrEP navigator or peer navigator 
would be helpful in supporting their PrEP use or who they want to talk to about PrEP 
13. PrEP Positives: This is when they talk about pros of using PrEP 
14. PrEP Concerns: This is when they express concern about certain aspects of PrEP but they aren’t 
outright refusing it 
15. PrEP Refusal Reasons: This is when they express something that would make them not take PrEP at 
all 
16. Prevention Methods: This is when they talk about prevention methods and also the difficulties of 
utilizing these methods 
17. Providers not talking about PrEP: This is when they say that providers have never spoken to them 
about PrEP 
18. Purpose of study: This is when they are curious about the study and how it will be used 
19. Remembering to take pill: This is when they express that they will not remember to take the pill or 
that they have trouble taking the pills they already have 
20. Risk perception: This is when they talk about how they perceive their own HIV or STI risk 
21. STI Concerns: This is when they talk about concerns they have with STIs 
22. Side effects: This is when they express concern with taking PrEP because of the side effects 
23. Stigma: This is when they talk about stigma from people in their community or their friends and family 
when it comes to taking PrEP 
24. Support from providers: This is when they talk about feeling supported by providers in relation to 
PrEP use or talking about PrEP 
25. Support from family/friends/significant others: This is when they talk about feeling supported by 
family/friends/significant others in relation to PrEP use or talking about PrEP 
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26. Support in taking PrEP: This is ways in which they explicitly say what would support them in taking 
PrEP 
27. Trusting friends and family: This is when they talk about trusting friends and family to receive medical 
information  
28. Trusting health providers: This is when they talk about trusting providers to receive medical 
information 
After my first initial round of coding, some concepts I see forming are barriers to PrEP use, facilitators to 
PrEP use, medical trust, HIV and PrEP knowledge, stigma, study reactions, and risk perception. During 
my next round of coding, I will be focusing in on these concepts to combine some of the 28 codes I have 
now. The way I am thinking about organizing them are as follows: 
Category: Barriers to PrEP use 
Codes: PrEP concerns, PrEP refusal reasons, Providers not talking about PrEP, Remembering to take the 
pill, Side effects, Medication use, Medication Interactions, Other disease interactions, Places they have 
seen PrEP 
Category: Facilitators to PrEP use 
Codes: PrEP motivation, PrEP navigator, comfortability talking about PrEP, PrEP positives, Support from 
providers, support from family/friends/significant others. Support in taking PrEP, Intention to use PrEP 
Category: Medical Trust 
Codes: trusting family and friends, trusting health providers 
Category: HIV and PrEP Knowledge 
Codes: HIV Knowledge, PrEP Knowledge, Prevention methods 
Category: Stigma 
Codes: Stigma, HIV risk 
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Category: Study Reactions 
Codes: Purpose of study, ACHD follow-up feelings 
Category: Risk Perception 
Codes: Risk Perception, STI Concerns 
Observations: 
So far, what I am seeing is interesting. The barriers to PrEP use were pretty much what I had expected 
them to based on of the literature. The facilitators are also pretty on par with what the literature said, 
except for the idea of a PrEP navigator, which is something that already exists, however, a more 
normalized and widespread use of them would be beneficial. It seems that in terms of an intervention that 
would be useful from the literature it would the SMS platform that sent reminder texts to participants.  
The other interesting trend I am seeing is that most of these participants have low HIV and PrEP 
knowledge which is skewing their idea of their risk perception. It is interesting because each of these 
participants has tested positive for 4 STIs at this point, but do not think they are at risk for HIV or they 
aren’t concerned at all about HIV. Another intervention that could be beneficial is to increase HIV and 
PrEP knowledge. I think the most important place for this to happen is within doctor’s offices and clinics, 
but even more importantly within sex education at school. That idea is definitely controversial, but it will 
never be possible to change risk perception and HIV knowledge and in turn PrEP knowledge without 
reaching them at an age that they are especially vulnerable to this disease.  
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Appendix C Grounded Theory Memo 2 
Memo #2 
3/2/21 
The second round of coding or axial coding is done. In this stage I created categories for 
the 28 codes made in open coding to fit into. There are 7 categories. They are below along with 
their definitions: 
1. Medical Trust- This category is when the woman describes trusting in healthcare 
providers or trusting in friends and family for medical/sexual health advice 
2. Barriers to PrEP Use- This category is for discussion points that describe the difficulties 
in PrEP use or what would make them not use PrEP 
3. Facilitators to PrEP Use- This category is for discussion points that talk about ways in 
which a woman might feel supported in taking PrEP or what would make it easier to take 
PrEP 
4. HIV, PrEP, and STI Knowledge- This is when the woman describes what she knows 
about PrEP and HIV either explicitly or when she is talking about circumstances 
surrounding PrEP and HIV, this is also when she is talking about prevention methods 
relating to HIV and STI's 
5. Risk Perception- This category is for when the woman describes her understanding of her 
own risk and when she talks about STI concerns as she is often describing her 
understanding of her risk for STI's 
6. Stigma- This category is when the woman is describing stigma that they would 
experience if they used PrEP and when they are displaying stigma and talking about what 
they think HIV and STI risk look like 
7. Study Reactions- This is when a woman talks about her feelings when ACHD reached 
out to her and when they speak about the purpose of the study/what they think would be 
helpful to study result 
 
Each category had several codes from the first round of coding attached to them. They are 
as follows:  
Category: Barriers to PrEP use 
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Codes: PrEP concerns, PrEP refusal reasons, Providers not talking about PrEP, Remembering to 
take the pill, Side effects, Medication use, Medication Interactions, Other disease interactions, 
Places they have seen PrEP 
Category: Facilitators to PrEP use 
Codes: PrEP motivation, PrEP navigator, comfortability talking about PrEP, PrEP positives, 
Support from providers, support from family/friends/significant others. Support in taking PrEP, 
Intention to use PrEP,  
Category: Medical Trust 
Codes: trusting family and friends, trusting health providers 
Category: HIV, PrEP and STI Knowledge 
Codes: HIV Knowledge, PrEP Knowledge, Prevention methods 
Category: Stigma 
Codes: Stigma, HIV risk 
Category: Study Reactions 
Codes: Purpose of study, ACHD follow-up feelings 
Category: Risk Perception 
Codes: Risk Perception, STI Concerns 
Upon further examination of the codes, the third round of coding will entail further defining 
prevention methods. There are two parts to that code. The first is when the woman talks about the 
prevention methods she uses and the second is when she talks about the easiest and hardest 
situations associated with using the prevention method. In this case, I think that I would create two 
additional codes that would be entitled “Barriers to using prevention methods” and “Facilitators to 
using prevention methods” As far as how I would code those in categories, I would likely add the 
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barriers one to Risk Perception because that will affect how a person views their risk or it won’t 
change it, but it probably should change it. I would add the facilitators one also to Risk Perception 
because this could affect how they view their risk of contracting STIs.  
As far as condensing categories,  I think that I am going to combine Medical Trust to 
facilitators of PrEP use, because these are people whom they trust to receive medical and sexual 
health advice from, this would facilitate PrEP use if they heard about PrEP from those people. I 
also think I am going to combine risk perception and stigma because when reviewing the 
interviews, those often occurred in tandem with each other.  
The categories for the third round will look like this: 
1. Barriers to PrEP Use 
2. Facilitators to PrEP Use 
3. HIV, PrEP, and STI Knowledge 
4. Stigma and Risk Perception 
5. Study Reactions 
 
Observations:  
On this second review of the interviews, it is still incredibly interesting to me how risk 
perception is so low considering the background of each of these women. They do not believe they 
are at risk for HIV. While the circumstances in which a person gets an STI vary and that can 
contribute to low risk perception, doctors need to make these women aware that just the actual 
getting of an STI can increase risk, no matter the manner in which you receive the STI.  
What is also interesting to me is the level of stigma that is associated with the behaviors 
that are considered risky. I didn’t think that stigma would be so high. In short it seems that the 
actual risk in the situation is high, stigma related to risky behaviors is high, but their own 
perception of what their risk is, is incredibly low. 
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An intervention that could be useful in this circumstance is sort of what the pocket guide 
that was mentioned in the literature achieves; except I think it is even more important to highlight 
their own risk after seeing this disconnect. I would recommend some type of assessment that they 
can take to see what their actual risk score is rather than only a doctor assessing the risk because 
it may not get through to the patient that they are actually at risk. I also think once again that an 
important consideration for adoption would the SMS platform intervention. It is a recurring theme 
in the barriers to PrEP use category that remembering to take the pill and worrying about side 
effects are major barriers. This intervention would help to remind but also provide real-time 
assistance to those who are taking PrEP.  
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